Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC reduced its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 31.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,194 shares of the medical instruments supplier's stock after selling 35,825 shares during the period. Janus Henderson Group PLC owned approximately 1.44% of Mesa Laboratories worth $10,153,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Amalgamated Bank raised its holdings in shares of Mesa Laboratories by 6.5% during the 3rd quarter. Amalgamated Bank now owns 1,588 shares of the medical instruments supplier's stock valued at $206,000 after buying an additional 97 shares during the period. Louisiana State Employees Retirement System raised its holdings in shares of Mesa Laboratories by 4.0% during the 2nd quarter. Louisiana State Employees Retirement System now owns 2,600 shares of the medical instruments supplier's stock valued at $226,000 after buying an additional 100 shares during the period. FMR LLC raised its holdings in shares of Mesa Laboratories by 34.1% during the 3rd quarter. FMR LLC now owns 393 shares of the medical instruments supplier's stock valued at $51,000 after buying an additional 100 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of Mesa Laboratories by 6.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,873 shares of the medical instruments supplier's stock valued at $316,000 after buying an additional 175 shares during the period. Finally, Public Sector Pension Investment Board raised its holdings in shares of Mesa Laboratories by 1.8% during the 3rd quarter. Public Sector Pension Investment Board now owns 11,461 shares of the medical instruments supplier's stock valued at $1,488,000 after buying an additional 200 shares during the period. 90.60% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Mesa Laboratories

In other news, CEO Gary M. Owens sold 2,518 shares of Mesa Laboratories stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $113.62, for a total value of $286,095.16. Following the completion of the transaction, the chief executive officer now owns 45,888 shares in the company, valued at approximately $5,213,794.56. This trade represents a 5.20 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Brian David Archbold sold 1,499 shares of Mesa Laboratories stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $125.00, for a total value of $187,375.00. The disclosure for this sale can be found here. Insiders own 4.40% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on MLAB shares. Wells Fargo & Company started coverage on Mesa Laboratories in a report on Tuesday, August 27th. They set an "underweight" rating and a $120.00 target price on the stock. StockNews.com downgraded Mesa Laboratories from a "buy" rating to a "hold" rating in a report on Wednesday, November 13th. Finally, Evercore ISI lifted their price objective on Mesa Laboratories from $120.00 to $160.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st.

Mesa Laboratories Stock Up 5.7 %

MLAB stock traded up $7.06 during midday trading on Monday, hitting $131.06. 36,119 shares of the company's stock were exchanged, compared to its average volume of 41,296. The company has a current ratio of 0.70, a quick ratio of 0.51 and a debt-to-equity ratio of 0.65. Mesa Laboratories, Inc. has a 12-month low of $83.68 and a 12-month high of $141.17. The firm has a 50 day moving average price of $120.09 and a 200-day moving average price of $114.78. The stock has a market capitalization of $711.66 million, a price-to-earnings ratio of -2.88 and a beta of 0.86.

Mesa Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 29th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, November 29th. This represents a $0.64 annualized dividend and a yield of 0.49%. Mesa Laboratories's dividend payout ratio is presently -1.40%.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.